TABLE 1.
Patient characteristics of the COVID-19 home monitoring cohort
| Total cohort (n=320) | Readmitted patients (n=23) | |
| Gender | ||
| Male | 206 (64) | 17 (74) |
| Age, years | 56±12 | 62±10 |
| COVID-19 diagnosis based on | ||
| PCR | 318 (99) | 23 (100) |
| Computed tomography | 1 (0.3) | 0 |
| Chest radiograph | 1 (0.3) | 0 |
| Underlying comorbidities | ||
| Diabetes mellitus | 39 (12) | 4 (17) |
| Hypertension | 89 (28) | 10 (43) |
| Obesity (BMI >30 kg·m−2) | 100 (31) | 3 (13) |
| Chronic pulmonary disease | 90 (28) | 11 (48) |
| Chronic heart disease | 54 (17) | 11 (48) |
| Immunocompromised state | 10 (3) | 1 (4) |
| Admission to intensive care unit | 54 (17) | 1 (4) |
| Length of stay on intensive care unit, days | 9±8.5 | 5 |
| Oxygen therapy during hospitalisation | ||
| Nasal oxygen or non-rebreather mask | 260 (82) | 21 (91) |
| Non-invasive ventilation or nasal high flow oxygen therapy | 45 (14) | 2 (9) |
| Intubation | 11 (3.4) | 0 |
| Duration of disease on admission to home monitoring, days | 18±9.1 | 15.6±10.5 |
| Length of hospitalisation, days | 8.6±6.6 | 6.8±5.2 |
| Fever at time of discharge | 7 (2) | 2 (9) |
| Oxygen therapy when discharged | ||
| Yes | 196 (61) | 16 (70) |
| No | 124 (39) | 7 (30) |
| Total reduction in length of hospitalisation, days | ||
| In need for oxygen therapy (n=189)# | 1200 | |
| No need for oxygen therapy (n=76)¶ | 141.5 | |
| Mean reduction in length of stay, days (n=265) | 5.1±3.4 | |
| Length of home monitoring, days | 11.7±5.4 | |
| Number of telephone contacts | 5.7±3.0 | |
Normally distributed data are presented as mean±sd; categorical data are presented as n (%). BMI: body mass index. #: seven patients were excluded due to re-admission or follow up in another hospital; ¶: in 31 patients, no reduction in length of stay was noted; in 17 patients, no reduction in length of stay was expected.